Literature DB >> 28987503

A Comparison of Staging Systems for Hepatocellular Carcinoma in a Multicenter US Cohort.

Neehar D Parikh1, Steve Scaglione2, Yumeng Li3, Corey Powell3, Olutola A Yerokun4, Pauline Devlin5, Shaham Mumtaz2, Sahil Mittal6, Amit G Singal4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28987503      PMCID： PMC5913743          DOI： 10.1016/j.cgh.2017.10.001

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  8 in total

1.  Model to estimate survival in ambulatory patients with hepatocellular carcinoma.

Authors:  Ju Dong Yang; W Ray Kim; Kyung Woo Park; Roongruedee Chaiteerakij; Bohyun Kim; Schuyler O Sanderson; Joseph J Larson; Rachel A Pedersen; Terry M Therneau; Gregory J Gores; Lewis R Roberts; Joong-Won Park
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

2.  A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.

Authors: 
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

3.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

4.  Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.

Authors:  Thomas Yau; Vikki Y F Tang; Tzy-Jyun Yao; Sheung-Tat Fan; Chung-Mau Lo; Ronnie T P Poon
Journal:  Gastroenterology       Date:  2014-02-25       Impact factor: 22.682

5.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

6.  Comparing Cox regression and parametric models for survival of patients with gastric carcinoma.

Authors:  Mohamad Amin Pourhoseingholi; Ebrahim Hajizadeh; Bijan Moghimi Dehkordi; Azadeh Safaee; Alireza Abadi; Mohammad Reza Zali
Journal:  Asian Pac J Cancer Prev       Date:  2007 Jul-Sep

7.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

8.  Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.

Authors:  Fabio Farinati; Alessandro Vitale; Gaya Spolverato; Timothy M Pawlik; Teh-la Huo; Yun-Hsuan Lee; Anna Chiara Frigo; Anna Giacomin; Edoardo G Giannini; Francesca Ciccarese; Fabio Piscaglia; Gian Lodovico Rapaccini; Mariella Di Marco; Eugenio Caturelli; Marco Zoli; Franco Borzio; Giuseppe Cabibbo; Martina Felder; Rodolfo Sacco; Filomena Morisco; Elisabetta Biasini; Francesco Giuseppe Foschi; Antonio Gasbarrini; Gianluca Svegliati Baroni; Roberto Virdone; Alberto Masotto; Franco Trevisani; Umberto Cillo
Journal:  PLoS Med       Date:  2016-04-26       Impact factor: 11.069
  8 in total
  9 in total

1.  Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.

Authors:  Steve Scaglione; William Adams; Allyce Caines; Pauline Devlin; Sahil Mittal; Amit G Singal; Neehar D Parikh
Journal:  Dig Dis Sci       Date:  2019-10-23       Impact factor: 3.199

2.  Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.

Authors:  Bo-Hao Zheng; Long-Zi Liu; Zhi-Zhi Zhang; Jie-Yi Shi; Liang-Qing Dong; Ling-Yu Tian; Zhen-Bin Ding; Yuan Ji; Sheng-Xiang Rao; Jian Zhou; Jia Fan; Xiao-Ying Wang; Qiang Gao
Journal:  BMC Cancer       Date:  2018-11-21       Impact factor: 4.430

Review 3.  Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Emily Harding-Theobald; Jeremy Louissaint; Bharat Maraj; Edward Cuaresma; Whitney Townsend; Mishal Mendiratta-Lala; Amit G Singal; Grace L Su; Anna S Lok; Neehar D Parikh
Journal:  Aliment Pharmacol Ther       Date:  2021-08-12       Impact factor: 9.524

Review 4.  Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation.

Authors:  Nitin N Katariya; Blanca C Lizaola-Mayo; David M Chascsa; Emmanouil Giorgakis; Bashar A Aqel; Adyr A Moss; Pedro Luiz Serrano Uson Junior; Mitesh J Borad; Amit K Mathur
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

5.  Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.

Authors:  Sophia Heinrich; Martin Sprinzl; Irene Schmidtmann; Elena Heil; Sandra Koch; Carolin Czauderna; Bernd Heinrich; Laurence Philippe P Diggs; Marcus-Alexander Wörns; Roman Kloeckner; Peter R Galle; Jens U Marquardt; Arndt Weinmann
Journal:  United European Gastroenterol J       Date:  2020-01-29       Impact factor: 4.623

Review 6.  Hepatocellular carcinoma: recent advances and emerging medical therapies.

Authors:  Kwan-Lung Ko; Lung-Yi Mak; Ka-Shing Cheung; Man-Fung Yuen
Journal:  F1000Res       Date:  2020-06-17

7.  Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population.

Authors:  Laura Bainy Rodrigues de Freitas; Larisse Longo; Deivid Santos; Ivana Grivicich; Mário Reis Álvares-da-Silva
Journal:  World J Hepatol       Date:  2019-09-27

8.  Evaluation of staging systems to predict prognosis in hepatocellular carcinoma patients treated with radioembolization.

Authors:  Ece Meram; Colin Longhurst; Baran Umut Vardar; Kerim Karaoglu; Paul F Laeseke; Orhan S Ozkan
Journal:  Heliyon       Date:  2022-01-13

9.  Prognostic Value of Macrophage-Associated Long Non-Coding RNA Expression for Hepatocellular Carcinoma.

Authors:  Guan-Yu Chen; Duo Wang
Journal:  Cancer Manag Res       Date:  2022-01-14       Impact factor: 3.989
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.